Shimadzu Corporation
Climate Impact & Sustainability Data (2020, 2021, 2022-04 to 2023-03, 2023-04 to 2024-03)
Reporting Period: 2020
Environmental Metrics
ESG Focus Areas
- Environmental
- Social
- Governance
Environmental Achievements
- Not disclosed
Social Achievements
- Established NARO Shimadzu Kyoto Laboratory for Food Innovation to analyze functionally beneficial components in food.
- Increased aftermarket sales ratio to 34% in Analytical & Measuring Instruments Business and 33% in Medical Systems Business.
Governance Achievements
- Not disclosed
Climate Goals & Targets
- Not disclosed
- Not disclosed
- Not disclosed
Environmental Challenges
- Declining birthrates and aging populations increasing healthcare costs.
- Growing global warming leading to water shortages and need for renewable energy.
- Sophistication of structural materials requiring compliance with safety regulations.
- COVID-19 pandemic impacting business conditions in various sectors.
- Data integrity concerns across industries.
Mitigation Strategies
- Developing infection testing technologies and solutions.
- Supplying systems for clean energy technologies.
- Improving product energy efficiency and consumable longevity.
- Offering network-compatible LabSolutions analytical data systems for data integrity and business process reform.
- Cost and expense reduction measures.
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Not disclosed
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Null
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed
Reporting Period: 2021
Environmental Metrics
ESG Focus Areas
- Climate Change
- Human Health
- Safety and Security of Society
- Sustainable Development Goals (SDGs)
- Circular Economy
- Diversity and Inclusion
- Governance
- Supply Chain Management
- Infectious Disease Countermeasures
Environmental Achievements
- Endorsed TCFD recommendations (June 2017), obtained Science Based Targets (SBT) initiative certification (November 2019), became a signatory to the RE100 declaration (March 2021) for achieving carbon-neutrality.
- Actively engaged in measures contributing to the environment, including the 3Rs (reduce, reuse, and recycle), and measures aimed at achieving a circular economy.
Social Achievements
- Launched infectious disease countermeasure projects, including providing mobile X-ray systems, reagent kits for detecting COVID-19, and a fully automated PCR testing system.
- Actively collaborating with academia, hospitals, and healthcare institutions to create systems for fighting infectious diseases.
- Focus on health and productivity management, promoting diversity management practices, and training human resources based on respect for differences and diversity.
Governance Achievements
- Strengthened internal controls.
- Established a new DX Strategy Management Department to promote digital transformation.
- Signed the United Nations Global Compact in September 2019.
Climate Goals & Targets
- Achieve carbon-neutrality (RE100 declaration)
Environmental Challenges
- Impact of the COVID-19 pandemic on business activities and working practices.
- Large differences in business conditions across regions, fields, and business categories.
- Achieving carbon-neutrality given the company's relatively small contribution to global emissions.
Mitigation Strategies
- Implemented infectious disease countermeasure projects.
- Optimized the business base by strengthening operations outside Japan.
- Implemented DX measures to improve efficiency and expand business opportunities.
- Developed more sophisticated sustainability management practices, including ESG measures and a “zero-carbon commitment”.
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: TCFD, SDGs, UN Global Compact
Certifications: Science Based Targets (SBT) initiative
Reporting Period: 2022-04 to 2023-03
Environmental Metrics
ESG Focus Areas
- Climate Change
- Diversity & Inclusion
- Governance
- Health & Wellbeing
- Supply Chain Sustainability
- Biodiversity
Environmental Achievements
- Reduced CO2 emissions by 78.8% from FY 2017 to 10,462 t-CO2 in FY 2022. 86% of total electricity consumption in FY 2022 was from renewable sources.
- Waste recycle rate of 99.67%
- CO2 reduction contribution of new products sold during FY 2022 was 8,884 tons.
Social Achievements
- Percentage of female managers in the consolidated Shimadzu Group increased by 0.7 points (year on year) to 10.9% in FY 2022.
- Percentage of male employees taking childcare leave in non-consolidated Shimadzu Corporation improved from 22.7% in FY 2020 to 56.7% in FY 2022.
- Launched Health Checkup Challenge, increasing average health score from 84.5 to 85.7 points.
Governance Achievements
- Established Group management regulations to strengthen governance capabilities.
- Established 240 managers responsible for implementing risk management practices and reassessing business processes.
- Shimadzu Group’s CO2 emission reduction target for FY 2030 was validated by the SBT initiative.
Climate Goals & Targets
- Reduce CO2 emissions from business activities to net-zero by FY 2050.
- Increase the percentage of renewable energy use to 100% by FY 2050.
- Reduce CO2 emissions from business activities by at least 90% by FY 2040 compared to FY 2017 levels.
- Ratio of female managers (consolidated) to 15% by FY 2030.
- Reduce CO2 emissions from business activities by at least 85% by FY 2030 compared to FY 2017 levels.
- Reduce CO2 emissions from the use of products sold by the Shimadzu Group by at least 30% by FY 2030 compared to FY 2020 levels.
- Increase the sales ratio of Eco-Products Plus models to 30% by FY 2030.
Environmental Challenges
- Supply chain disruptions due to parts and materials procurement difficulties and the China lockdown.
- Compliance issues at subsidiaries.
- Development delays due to the COVID-19 pandemic and supply difficulties.
- Economic security and geopolitical risks.
- Inadequate assessment systems leading to employee dissatisfaction.
- Insufficient training resulting in lack of appreciation for service work ethics.
Mitigation Strategies
- Acquired Nissui Pharmaceutical (renamed Shimadzu Diagnostics Corporation) to generate synergies in healthcare.
- Established a new medium-term management plan to increase corporate value.
- Strengthened Group governance capabilities and implemented cultural reforms.
- Established three lines of defense for risk management.
- Reconsidered assessment criteria and training content.
- Established supervising/monitoring capabilities and eliminated dual roles.
- Strengthened internal reporting function.
Supply Chain Management
Supplier Audits: 100% (Percentage of orders placed by subcontractors) by FY 2025
Responsible Procurement
- CSR self-assessments by suppliers
- Collaboration with Bank of Kyoto to support supplier sustainability initiatives.
Climate-Related Risks & Opportunities
Physical Risks
- Extreme weather events (wind and flood disasters)
Transition Risks
- Carbon pricing
- Sharp price increases for products in highly energy-intensive industries
- Decreased demand for products for fossil fuel industries
- Intensified competition in technology development
Opportunities
- Increased demand for energy-efficient products
- Increased demand for products related to clean energy, batteries, and new materials.
Reporting Standards
Frameworks Used: TCFD, SBT, UNGC, TNFD
Certifications: Eco-First Company
UN Sustainable Development Goals
- SDG 3
- SDG 6
- SDG 7
- SDG 9
- SDG 12
- SDG 13
Shimadzu's initiatives contribute to these goals through various activities related to health, clean water, renewable energy, sustainable infrastructure, responsible consumption and production, and climate action.
Sustainable Products & Innovation
- Eco-Products Plus
Awards & Recognition
- Health and Productivity Management Brand (3 consecutive years)
- White 500 Company with Superior Health Management (7 consecutive years)
- Minister of the Environment's Award for Achievement in Promoting a Recycling-Oriented Society (2021)
Reporting Period: 2023-04 to 2024-03
Environmental Metrics
ESG Focus Areas
- Environment
- Society
- Governance
Environmental Achievements
- Reduced CO2 emissions by 78.2% compared to FY2017 to 10,778 t-CO2, due to switching to renewable energy.
- 85% of total electricity consumption in FY2023 was from renewable energy sources.
- Achieved a 99.70% waste recycling rate for 14 consecutive years.
Social Achievements
- Increased percentage of female managers in the consolidated Shimadzu Group to 11.1% in FY2023.
- Increased percentage of male employees taking childcare leave.
- Number of employees participating in health promotion events reached 6,332.
Governance Achievements
- 100% of Group companies notified of Shimadzu Group Management Basic Regulation.
- 96% implementation of CSR self-assessment and supplier communication.
- Implemented corrective measures for fraud at Shimadzu Medical Systems Corporation.
Climate Goals & Targets
- Reduce CO2 emissions from business activities to net-zero by 2050.
- Reduce CO2 emissions from business activities by at least 90% by FY2040 compared to FY2017 levels.
- Increase the sales ratio of Eco-Products Plus models to 30% by FY2030.
- Achieve at least 15% female managers in consolidated Shimadzu by FY2030.
- Reduce CO2 emissions from business activities by at least 85% by FY2030 compared to FY2017 levels.
- Reduce CO2 emissions from the use of products sold by the Shimadzu Group by at least 30% by FY2030 compared to FY2020 levels.
Environmental Challenges
- Worsening market conditions in China.
- Longer than expected development and approval processes in Med-Tech business.
- Low operating margins in medical systems and industrial machinery segments.
- Fraudulent practices at Shimadzu Medical Systems Corporation.
Mitigation Strategies
- Integrated sales units into the Sales & Marketing Division.
- Accelerated development and approval processes in Med-Tech by modifying strategies and bolstering human resources.
- Implementing measures to increase operating margins.
- Implemented corrective measures and recurrence prevention measures for fraud at Shimadzu Medical Systems Corporation.
Supply Chain Management
Supplier Audits: 96% of suppliers conducted CSR self-assessments.
Responsible Procurement
- CSR self-assessments
- Supplier communication
Climate-Related Risks & Opportunities
Physical Risks
- Wind and flood disasters
- Supply chain disruptions
Transition Risks
- Carbon pricing
- Sharp price increases for products in highly energy-intensive industries
- Decreased demand for products for fossil fuel industries
Opportunities
- Increased demand for energy-efficient products
- Increased demand for products related to renewable energy
- Increased demand for products used to improve battery and storage system performance
- Increased demand for products related to R&D of CO2 adsorbents
- Increased demand for products related to development, quality control, and evaluation of biomass resources
- Increased demand for material testing machines and products related to surface analysis of new materials
- Increased demand for products related to semiconductors
Reporting Standards
Frameworks Used: TCFD, SBT, RE100, UN Global Compact
Certifications: Eco-First
UN Sustainable Development Goals
- Goal 7 (Affordable and clean energy)
- Goal 9 (Industry, innovation, and infrastructure)
- Goal 12 (Responsible consumption and production)
- Goal 13 (Climate action)
- Goal 3 (Good health and well-being)
Shimadzu's initiatives contribute to these goals through renewable energy use, development of sustainable products, waste reduction, CO2 emission reduction, and advancements in healthcare technologies.
Sustainable Products & Innovation
- Eco-Products Plus
- Products made with flame retardant cellulose fiber-reinforced composite plastic
Awards & Recognition
- 2023 Best 10 New Products Award (Brevis GC-2050)